Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13.1M
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
11.3M
-
Shares change
-
-891K
-
Total reported value, excl. options
-
$573M
-
Value change
-
-$47.7M
-
Number of buys
-
64
-
Number of sells
-
-74
-
Price
-
$50.92
Significant Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q4 2021
173 filings reported holding EGRX - EAGLE PHARMACEUTICALS, INC. - Common Stock as of Q4 2021.
EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.3M shares
of 13.1M outstanding shares and own 86.1% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.97M shares), JANUS HENDERSON GROUP PLC (1.53M shares), VANGUARD GROUP INC (760K shares), STATE STREET CORP (708K shares), BRANDES INVESTMENT PARTNERS, LP (614K shares), DIMENSIONAL FUND ADVISORS LP (290K shares), Allspring Global Investments Holdings, LLC (275K shares), AMERIPRISE FINANCIAL INC (267K shares), JPMORGAN CHASE & CO (244K shares), and Smith, Graham & Co., Investment Advisors, LP (236K shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.